For instance, a study conducted primarily in a sample of patients with statin-induced myopathy ascertained through neurology clinics indicated that up to 10% of statin-intolerant subjects were heterozygous or homozygous for disease-causing mutations in rare metabolic myopathies, namely carnitine palmitoyl transferase II deficiency and McArdle disease [7]. Here, CPT2 is linked to glycogen storage disease V.